Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Riedl

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|March 4, 2016
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand EfficienciesThomas Fischer, Rainer Riedl
Angewandte Chemie (International Ed. in English)|September 13, 2017
Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA PolymeraseMathieu F Chellat, Rainer Riedl
Drug Discovery Today|September 14, 2024
Targeted protein degradation: current molecular targets, localization, and strategiesDimanthi Pliatsika, Cindy Blatter, Rainer Riedl
Expert Opinion on Drug Discovery|June 11, 2019
Approaching Target Selectivity by De Novo Drug DesignThomas Fischer, Silvia Gazzola, Rainer Riedl
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 6, 2019
Design and Structural Evolution of Matrix Metalloproteinase InhibitorsThomas Fischer, Nicole Senn, Rainer Riedl
Angewandte Chemie (International Ed. in English)|March 23, 2016
Targeting Antibiotic ResistanceMathieu F Chellat, Luka Raguž, Rainer Riedl
Archiv Der Pharmazie|December 9, 2024
Phthalimide derivatives as a new class of papain-like protease inhibitors in SARS-CoV-2Thomas Fischer, David Frasson, Martin Sievers, et al.
Chimia|December 15, 2010
Thermal cleavage of the fmoc protection groupStefan Höck, Roger Marti, Rainer Riedl, et al.
Journal of Medicinal Chemistry|September 28, 2017
Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 InhibitorNicole Senn, Michael Ott, Jan Lanz, et al.
Angewandte Chemie (International Ed. in English)|May 31, 2018
A Structural View on Medicinal Chemistry Strategies against Drug ResistanceStefano Agnello, Michael Brand, Mathieu F Chellat, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|March 4, 2016
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand EfficienciesThomas Fischer, Rainer Riedl
Angewandte Chemie (International Ed. in English)|September 13, 2017
Pseudouridimycin: The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA PolymeraseMathieu F Chellat, Rainer Riedl
Drug Discovery Today|September 14, 2024
Targeted protein degradation: current molecular targets, localization, and strategiesDimanthi Pliatsika, Cindy Blatter, Rainer Riedl
Expert Opinion on Drug Discovery|June 11, 2019
Approaching Target Selectivity by De Novo Drug DesignThomas Fischer, Silvia Gazzola, Rainer Riedl
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 6, 2019
Design and Structural Evolution of Matrix Metalloproteinase InhibitorsThomas Fischer, Nicole Senn, Rainer Riedl
Angewandte Chemie (International Ed. in English)|March 23, 2016
Targeting Antibiotic ResistanceMathieu F Chellat, Luka Raguž, Rainer Riedl
Archiv Der Pharmazie|December 9, 2024
Phthalimide derivatives as a new class of papain-like protease inhibitors in SARS-CoV-2Thomas Fischer, David Frasson, Martin Sievers, et al.
Chimia|December 15, 2010
Thermal cleavage of the fmoc protection groupStefan Höck, Roger Marti, Rainer Riedl, et al.
Journal of Medicinal Chemistry|September 28, 2017
Targeted Polypharmacology: Discovery of a Highly Potent Non-Hydroxamate Dual Matrix Metalloproteinase (MMP)-10/-13 InhibitorNicole Senn, Michael Ott, Jan Lanz, et al.
Angewandte Chemie (International Ed. in English)|May 31, 2018
A Structural View on Medicinal Chemistry Strategies against Drug ResistanceStefano Agnello, Michael Brand, Mathieu F Chellat, et al.
Pageof 5